Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion type Assertion NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_head.
- NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion description "[Cockayne syndrome (CS) cells and xeroderma pigmentosum (XP) cells (XPD, XPA, XPG, and XPF) were defective in Pol II degradation, whereas XPC cells whose defect is limited to global genome NER in nontranscribing regions were proficient for Pol II degradation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_provenance.
- NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion evidence source_evidence_literature NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_provenance.
- NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion SIO_000772 18927284 NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_provenance.
- NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion wasDerivedFrom befree-2016 NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_provenance.
- NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_assertion wasGeneratedBy ECO_0000203 NP698522.RAHUeI_soEctdB4X194XNmQesfwR_lxisUsmLBBZ00mF0130_provenance.